Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice.
Nakashima Y, Kondo M, Shono E, Ishinishi T, Tsukamoto H, Kuroda K, Maeyama A, Harada H, Maekawa M, Shimauchi T, Nagamine R, Jojima H, Yoshizawa S, Tsuru T, Otsuka T, Miyahara H, Suematsu E, Wada K, Yoshizawa S, Inoue Y, Fukuda T, Ikemura S, Haraguchi A. Nakashima Y, et al. Among authors: maeyama a. Mod Rheumatol. 2020 Sep;30(5):807-815. doi: 10.1080/14397595.2019.1676369. Epub 2019 Oct 17. Mod Rheumatol. 2020. PMID: 31580188
Bone morphology and physical characteristics of the pro-cyclist hip joint.
Akiho S, Hashida R, Tagawa Y, Maeyama A, Kinoshita K, Kanazawa K, Matsuse H, Hara M, Yamamoto T. Akiho S, et al. Among authors: maeyama a. Int Orthop. 2024 Jul;48(7):1879-1886. doi: 10.1007/s00264-024-06196-3. Epub 2024 May 3. Int Orthop. 2024. PMID: 38700698 Free PMC article.
Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses.
Nakashima Y, Miyahara H, Kondo M, Fukuda T, Harada H, Haraguchi A, Inoue Y, Ishinishi T, Maekawa M, Maeyama A, Nakashima M, Shono E, Suematsu E, Shimauchi T, Tsuru T, Tsukamoto H, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: maeyama a. Mod Rheumatol. 2017 Jan;27(1):15-21. doi: 10.3109/14397595.2016.1170958. Epub 2016 May 4. Mod Rheumatol. 2017. PMID: 27142240
Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production.
Yamada H, Tsuru T, Otsuka T, Maekawa M, Harada H, Fukuda T, Tsukamoto H, Maeyama A, Yoshizawa S, Wada K, Nakashima Y, Shono E, Yoshizawa S, Jojima H, Kondo M. Yamada H, et al. Among authors: maeyama a. Immunol Med. 2020 Jun;43(2):87-91. doi: 10.1080/25785826.2020.1718833. Epub 2020 Jan 29. Immunol Med. 2020. PMID: 31994996 Free article.
A case of extrapulmonary tuberculosis after use of baricitinib.
Shimada T, Maeyama A, Hagio T, Muraoka K, Shibata T, Yamasaki Y, Oda T, Hamasaki M, Yamamoto T. Shimada T, et al. Among authors: maeyama a. Mod Rheumatol Case Rep. 2023 Jun 19;7(2):364-367. doi: 10.1093/mrcr/rxac098. Mod Rheumatol Case Rep. 2023. PMID: 36571561
Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
Harada H, Kondo M, Maeyama A, Fukuda T, Ikemura S, Shono E, Tsuru T, Inoue Y, Yoshizawa S, Niiro H, Nakashima Y. Harada H, et al. Among authors: maeyama a. Clin Rheumatol. 2024 May;43(5):1447-1459. doi: 10.1007/s10067-023-06862-8. Epub 2024 Jan 6. Clin Rheumatol. 2024. PMID: 38182801
Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
Harada H, Kondo M, Maeyama A, Fukuda T, Ikemura S, Shono E, Tsuru T, Inoue Y, Yoshizawa S, Niiro H, Nakashima Y. Harada H, et al. Among authors: maeyama a. Clin Rheumatol. 2024 May;43(5):1787-1791. doi: 10.1007/s10067-024-06907-6. Clin Rheumatol. 2024. PMID: 38489137 No abstract available.
73 results